Health and Healthcare

Amgen : AMGN

All Amgen Articles

699 Articles

Lee Jackson | Apr 23, 2019 at 7:40 AM EDT

Why 5 Lagging Health Care Giants May Be Incredible Buys Now

Jefferies did a deep dive into the health care sector, looking for underperforming stocks that could hold some solid value…

Chris Lange | Apr 10, 2019 at 9:15 AM EDT

Big Biotechs Confound Short Sellers

The March 29 short interest data have been compared with the previous report, and short interest moves in these selected…

Chris Lange | Mar 27, 2019 at 8:30 AM EDT

Big Biotechs Scare Off Short Sellers

The March 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Mar 12, 2019 at 9:05 AM EDT

Major Biotechs See a Rising Tide in Short Interest

The February 28 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Feb 28, 2019 at 8:35 AM EST

Short Sellers Can’t Make Up Their Minds on Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data…

Trey Thoelcke | Feb 22, 2019 at 8:00 AM EST

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a…

Chris Lange | Feb 12, 2019 at 9:55 AM EST

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 31 short interest data…

Jon C. Ogg | Jan 29, 2019 at 3:01 PM EST

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower…

Chris Lange | Jan 28, 2019 at 8:30 AM EST

Short Sellers Back Off Major Biotechs

The January 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jan 11, 2019 at 8:25 AM EST

Major Biotechs Scare Off Short Sellers

The December 31 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jan 3, 2019 at 1:25 PM EST

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Teva Pharmaceutical shares made a handy gain on Thursday after it was announced that the firm has settled with Amgen…

Chris Lange | Dec 27, 2018 at 8:25 AM EST

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The December 14 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Dec 12, 2018 at 8:40 AM EST

Short Sellers Still Can’t Make Up Their Mind on Major Biotech Stocks

The November 30 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Nov 28, 2018 at 8:20 AM EST

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The November 15 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Nov 12, 2018 at 8:50 AM EST

Short Sellers Raise the Stakes in Major Biotechs

The October 31 short interest data have been compared with the previous report, and short interest in most of the…

1 … 13 14 15 16 17 … 47

Amgen : AMGN

All Amgen Articles

Why 5 Lagging Health Care Giants May Be Incredible Buys Now

Big Biotechs Confound Short Sellers

Big Biotechs Scare Off Short Sellers

Major Biotechs See a Rising Tide in Short Interest

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Short Sellers Run for Cover From Major Biotechs

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Short Sellers Back Off Major Biotechs

Major Biotechs Scare Off Short Sellers

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Still Can’t Make Up Their Mind on Major Biotech Stocks

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Raise the Stakes in Major Biotechs

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Amgen : AMGN

All Amgen Articles

Why 5 Lagging Health Care Giants May Be Incredible Buys Now

Big Biotechs Confound Short Sellers

Big Biotechs Scare Off Short Sellers

Major Biotechs See a Rising Tide in Short Interest

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Short Sellers Run for Cover From Major Biotechs

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Short Sellers Back Off Major Biotechs

Major Biotechs Scare Off Short Sellers

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Still Can’t Make Up Their Mind on Major Biotech Stocks

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Raise the Stakes in Major Biotechs

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%